Short Sellers Retreat From Major Semiconductors in March
The short interest data have come out for the March 31 settlement date. On the broad scope, short sellers have backed off these semiconductor stocks.
All Work
Chris Lange
Short Interest Continues to Back Off Major Oil
With oil prices seemingly on the path to recovery and global markets slowly getting stronger, short interest is now more important than ever to follow.
Alcoa Sinks Despite Bottom Line Earnings Beat
Alcoa Inc. (NYSE: AA) reported its first quarter financial results after the markets closed on Monday. The aluminum giant had $0.07 in earnings per share (EPS) on $4.95 billion in revenue compared to the…
Raptor Pharmaceuticals Drops Despite European Launch
Raptor Pharmaceuticals saw its shares sink on Monday after it announced its first commercial sale of Quinsair in Germany and Denmark.
What to Expect From Alcoa Earnings
Aluminum producer Alcoa is scheduled to report its first-quarter financial results after the markets close on Monday.
Hertz Stumbles Over Weak Business Update
Hertz Global said it now expects its first-quarter U.S. car rental revenue and first-quarter earnings per share to be lower than previously expected.
Hatteras Rises on Annaly Acquisition
Annaly Capital Management and Hatteras Financial have announced the signing of a definitive merger agreement under which Annaly will acquire Hatteras in a cash and stock deal.
Insys Therapeutics Sinks on Missed Revenue Estimates
Insys Therapeutics watched its stock slide early Monday morning following the release of less-than-favorable revenue estimates.
Top 6 Companies Kicking Off Earnings Season
24/7 Wall St. has put together a preview of Alcoa, Bank of America and some of the other major companies reporting their quarterly results this week.
4 Key Biopharma Movers of the Past Week
Over the past week, Valeant Pharmaceuticals and a few other biotech companies made impressive runs.
The 5 Stocks Holding Back the Dow
Goldman Sachs continues to lead the list as the worst Dow performer in 2016. The top three worst performing Dow stocks are all financial companies.
Is Ambarella Already Fully Valued?
Oppenheimer initiated coverage of Ambarella with a Perform rating and no price target.
Wholesale Trade Numbers Edge Out Estimates
The U.S. Census Bureau has announced the February 2016 sales of merchant wholesalers.
Why Depomed Is Rising on Activist Pressure
Depomed saw its stock surge early Friday morning following news of an open letter from activist firm Starboard Value.
Las Vegas Sands Settles FCPA Charges With SEC
The SEC has announced that Las Vegas Sands has agreed to pay $9 million in penalties to settle charges that it violated the Foreign Corrupt Practices Act.
Why Jefferies Hit the Brakes on the Top Performing Dow Stock
Jefferies is downgrading Verizon Communications to a Hold rating but maintaining a $53 price target, citing elusive growth and strategic uncertainty.
Ionis Stumbles on FDA Clinical Hold
Ionis Pharmaceuticals made waves in the market on Thursday following a business update on its IONIS-TTR program.
Aeglea BioTherapeutics Enters the Market Way Below Expected Price Range
Aeglea BioTherapeutics entered the market quietly on Thursday morning, with pricing below the expected range of $16 to $18 per share.
JD Power Survey Finds Charles Schwab Best in Investor Satisfaction
J.D. Power’s Full Service Investor Satisfaction Study highlighted how a steadily increasing number of investment advisory customers have disrupted conventional thinking about full-service and self-directed advisory services.
Jobless Claims Hover Near Record Lows
Currently, jobless claims are holding at record lows, indicating a lack of layoffs and ongoing strength for the nation's labor market.